Richardson Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Richardson Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Sell	210 -667	-76%	-$296K	0.06%	230
2026 Q1	$392K	Sell	877 -75	-8%	-$35K	0.25%	100
2025 Q4	$432K	Buy	952 +10	+1%	+$4.31K	0.14%	90
2025 Q3	$369K	Sell	942 -78	-8%	-$32.6K	0.23%	101
2025 Q2	$461K	Buy	1,020 +6	+0.6%	+$2.77K	0.31%	93
2025 Q1	$492K	Buy	1,014 +40	+4%	+$18.6K	0.37%	82
2024 Q4	$389K	Buy	974 +8	+0.8%	+$3.71K	0.27%	97
2024 Q3	$453K	Buy	966 +4	+0.4%	+$1.92K	0.29%	87
2024 Q2	$451K	Buy	962 +25	+3%	+$10.9K	0.32%	82
2024 Q1	$392K	Buy	937 +340	+57%	+$144K	0.28%	96
2023 Q4	$243K	Buy	+597	New	+$221K	0.21%	109

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Richardson Financial Services's VRTX Position: Q2 2026 in Review

Richardson Financial Services reduced its Vertex Pharmaceuticals (VRTX) stake by 76% in Q2 2026, selling an estimated $296K and leaving 210 shares worth $104K. The position accounts for 0.06% of the portfolio, ranked #230.

Richardson Financial Services first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $492K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Richardson Financial Services held 210 shares of Vertex Pharmaceuticals worth $104K as of Q2 2026.
Richardson Financial Services sold 667 Vertex Pharmaceuticals shares in Q2 2026, an estimated $296K.
Vertex Pharmaceuticals made up 0.06% of Richardson Financial Services's portfolio in Q2 2026, its #230 holding.
Richardson Financial Services first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Richardson Financial Services's Vertex Pharmaceuticals position peaked at $492K in Q1 2025.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.